SEC Tracker
Get the app

Intellia Therapeutics NTLA

Intellia Therapeutics (NTLA) - Dube Michael P sold 1,864 shares

Michael P Dube, insider filing for NTLA

Form
4
Filed
Importance
Routine
  1. Oct 2, 2026 - Sold 1,864 shares
  2. Price per share: $12.43
  3. Total shares owned after transaction: 65,022
  4. Transaction type: Sell-to-cover for tax obligations

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Intellia Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.

  1. Geron GERN public float $861M, Jun 30, 2025
  2. Wave Life Sciences WVE public float $851M, Jun 30, 2025
  3. Cyanotech CYAN
  4. CorMedix CRMD public float $910M, Jun 30, 2025
  5. Ardelyx ARDX public float $924M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.